Literature DB >> 12689650

The paroxysm of Plasmodium vivax malaria.

Nadira D Karunaweera1, Subadra K Wijesekera, Deepani Wanasekera, Kamini N Mendis, Richard Carter.   

Abstract

The paroxysms of Plasmodium vivax malaria are antiparasite responses that, although distressing to the human host, almost never impart serious acute pathology. Using plasma and blood cells from P. vivax patients, the cellular and noncellular mediators of these events have been studied ex vivo. The host response during a P. vivax paroxysm was found to involve T cells, monocytes and neutrophils, and the activity, among others, of the pyrogenic cytokines tumor necrosis factor alpha and interleukin 2 in addition to granulocyte macrophage-colony stimulating factor. However, interferon gamma activity, associated with serious acute pathogenesis in other studies on malaria, was absent. Induction of the cytokines active during a P. vivax paroxysm depends upon the presence of parasite products, which are released into the plasma before the paroxysm. Chemical identification of these natural parasite products will be important for our understanding of pathogenesis and protection in malaria.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12689650     DOI: 10.1016/s1471-4922(03)00036-9

Source DB:  PubMed          Journal:  Trends Parasitol        ISSN: 1471-4922


  31 in total

1.  Hemoglobinopathic erythrocytes affect the intraerythrocytic multiplication of Plasmodium falciparum in vitro.

Authors:  Svetlana Glushakova; Amanda Balaban; Philip G McQueen; Rosane Coutinho; Jeffery L Miller; Ralph Nossal; Rick M Fairhurst; Joshua Zimmerberg
Journal:  J Infect Dis       Date:  2014-03-31       Impact factor: 5.226

2.  Plasmodium vivax vaccine research: insights from Colombian studies.

Authors:  Falgunee K Parekh; Vasee S Moorthy
Journal:  Am J Trop Med Hyg       Date:  2011-02       Impact factor: 2.345

Review 3.  Parasite virulence, co-infections and cytokine balance in malaria.

Authors:  Raquel Müller Gonçalves; Nathália Ferreira Lima; Marcelo Urbano Ferreira
Journal:  Pathog Glob Health       Date:  2014-05-23       Impact factor: 2.894

4.  Population dynamics of a pathogen: the conundrum of vivax malaria.

Authors:  Philip G McQueen
Journal:  Biophys Rev       Date:  2010-08-10

5.  Characterization of Plasmodium vivax transmission-blocking activity in low to moderate malaria transmission settings of the Colombian Pacific coast.

Authors:  Myriam Arévalo-Herrera; Yezid Solarte; Leonardo Rocha; Diego Alvarez; John C Beier; Sócrates Herrera
Journal:  Am J Trop Med Hyg       Date:  2011-02       Impact factor: 2.345

6.  Plasma superoxide dismutase-1 as a surrogate marker of vivax malaria severity.

Authors:  Bruno B Andrade; Antonio Reis-Filho; Sebastião Martins Souza-Neto; Imbroinise Raffaele-Netto; Luis M A Camargo; Aldina Barral; Manoel Barral-Netto
Journal:  PLoS Negl Trop Dis       Date:  2010-04-06

7.  Greater endothelial activation, Weibel-Palade body release and host inflammatory response to Plasmodium vivax, compared with Plasmodium falciparum: a prospective study in Papua, Indonesia.

Authors:  Tsin W Yeo; Daniel A Lampah; Emiliana Tjitra; Kim Piera; Retno Gitawati; Enny Kenangalem; Ric N Price; Nicholas M Anstey
Journal:  J Infect Dis       Date:  2010-07-01       Impact factor: 5.226

8.  Cytokine balance in human malaria: does Plasmodium vivax elicit more inflammatory responses than Plasmodium falciparum?

Authors:  Raquel M Gonçalves; Kézia K G Scopel; Melissa S Bastos; Marcelo U Ferreira
Journal:  PLoS One       Date:  2012-09-04       Impact factor: 3.240

9.  Uric acid is a mediator of the Plasmodium falciparum-induced inflammatory response.

Authors:  Jamie Marie Orengo; Aleksandra Leliwa-Sytek; James E Evans; Barbara Evans; Diana van de Hoef; Marian Nyako; Karen Day; Ana Rodriguez
Journal:  PLoS One       Date:  2009-04-17       Impact factor: 3.240

10.  Severe Plasmodium vivax malaria exhibits marked inflammatory imbalance.

Authors:  Bruno B Andrade; Antonio Reis-Filho; Sebastião M Souza-Neto; Jorge Clarêncio; Luis M A Camargo; Aldina Barral; Manoel Barral-Netto
Journal:  Malar J       Date:  2010-01-13       Impact factor: 2.979

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.